NCT07319767 2026-04-06Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant TumorsShanghai Zhongshan HospitalCompleted120 enrolled
NCT04003636 2026-03-24KEYNOTE-966Merck Sharp & Dohme LLCPhase 3 Completed1,069 enrolled 19 charts 2 FDA
NCT04426669 2026-02-23A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic EngineeringIntima Bioscience, Inc.Phase 1/2 Completed23 enrolled